186 related articles for article (PubMed ID: 35008223)
1. Survival Benefit of Resection Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastases: A Propensity Score-Matched SEER Database Analysis.
Pausch TM; Liu X; Cui J; Wei J; Miao Y; Heger U; Probst P; Heap S; Hackert T
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008223
[TBL] [Abstract][Full Text] [Related]
2. Survival benefit of surgical resection for stage IV gastric cancer: A SEER-based propensity score-matched analysis.
Sun J; Nan Q
Front Surg; 2022; 9():927030. PubMed ID: 36386506
[TBL] [Abstract][Full Text] [Related]
3. Survival Benefit of Surgical Resection for Pancreatic Neuroendocrine Tumors With Oligometastatic Liver Metastasis: A Retrospective and Propensity Score-Matching Analysis.
Yang Z; Liang J; Leng K; Shi G
Front Oncol; 2022; 12():903560. PubMed ID: 35847865
[TBL] [Abstract][Full Text] [Related]
4. Survival Benefit from Cancer-Directed Surgery for Metastatic Head and Neck Cancer.
Zhu R; Zhu H
Laryngoscope; 2024 Mar; 134(3):1288-1298. PubMed ID: 37658720
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing optimal candidates for primary tumor resection in patients with metastatic lung adenocarcinoma: A predictive model based on propensity score matching.
Qi Y; Guo X; Li Z; Ren B; Wang Z
Heliyon; 2024 Apr; 10(7):e27768. PubMed ID: 38690000
[TBL] [Abstract][Full Text] [Related]
6. Influence of cancer-directed surgery on the prognosis of liver metastases from gastric cancer.
Ji NN; Wu XW; Cao Q; Liu R; Tu W; Zeng YC; Li ZH
Clin Transl Oncol; 2024 Mar; 26(3):756-764. PubMed ID: 37606846
[TBL] [Abstract][Full Text] [Related]
7. Whether early stage pancreatic ductal adenocarcinoma patients could benefit from the post-operation chemotherapy regimens: a SEER-based propensity score matching study.
Shi J; Li X; Wu Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 50(3):375-382. PubMed ID: 34402250
[TBL] [Abstract][Full Text] [Related]
8. Survival benefit of local consolidative therapy for patients with single-organ metastatic pancreatic cancer: a propensity score-matched cross-sectional study based on 17 registries.
Hu X; Hu D; Fu B; Li H; Ren G; Liu H; Song J; Kang X; Wang X; Pang H; Liu C; Zhang J; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1225979. PubMed ID: 38027134
[TBL] [Abstract][Full Text] [Related]
9. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of chemotherapy in different histological types of pancreatic cancer: a PSM-based study using the SEER database.
Luo C; Fan L; Lun W; Ma M; Liang L; Yu C
J Chemother; 2024 Apr; 36(2):167-178. PubMed ID: 38481380
[TBL] [Abstract][Full Text] [Related]
11. Stage IA Patients With Pancreatic Ductal Adenocarcinoma Cannot Benefit From Chemotherapy: A Propensity Score Matching Study.
Zhang Y; Xu G; Chen M; Wei Q; Zhou T; Chen Z; Shen M; Wang P
Front Oncol; 2020; 10():1018. PubMed ID: 32766130
[No Abstract] [Full Text] [Related]
12. Does Surgical Resection Significantly Prolong the Long-Term Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma? A Cross-Sectional Study Based on 18 Registries.
Li Z; Zhang X; Sun C; Li Z; Fei H; Zhao D
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675442
[TBL] [Abstract][Full Text] [Related]
13. [The comparison of prognosis and risk factors after radical resection for pancreatic ductal adenocarcinoma between China Pancreas Data Center and SEER].
Hu H; Qu C; Tian XD; Yang YM
Zhonghua Wai Ke Za Zhi; 2021 Sep; 59(9):773-779. PubMed ID: 34404176
[No Abstract] [Full Text] [Related]
14. The exploration of surgery and survival prediction in patients with peritoneal metastasis from gastric adenocarcinoma based on the SEER database.
Shen Y; Yu S; Zhang Y; Wang S; Chen J; Xu Y; Hu X; Li J; Jiang S; Wang L; Xu L; Zhou Z; Deng J; Chen B; Xu X
J Gastrointest Oncol; 2024 Apr; 15(2):597-611. PubMed ID: 38756631
[TBL] [Abstract][Full Text] [Related]
15. Colorectal adenocarcinoma patients with M1a diseases gain more clinical benefits from palliative primary tumor resection than those with M1b diseases: A propensity score matching analysis.
Li CL; Tang DR; Ji J; Zang B; Chen C; Zhao JQ
World J Clin Cases; 2020 Aug; 8(15):3230-3239. PubMed ID: 32874977
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases.
Wu L; Lu Y; Chen L; Yue X; Cen C; Zheng C; Han P
Curr Oncol; 2022 Oct; 29(10):7912-7924. PubMed ID: 36290902
[TBL] [Abstract][Full Text] [Related]
18. Surgery and chemotherapy improve the prognosis of primary hepatic angiosarcoma: A retrospective study based on Propensity score matched survival analysis.
Jiang S; Wu H; Lu M; Li N
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):690-698. PubMed ID: 33239254
[TBL] [Abstract][Full Text] [Related]
19. Clinical features, treatment, and prognosis of different histological types of primary small bowel adenocarcinoma: A propensity score matching analysis based on the SEER database.
Zhou YW; Xia RL; Chen YY; Ma XL; Liu JY
Eur J Surg Oncol; 2021 Aug; 47(8):2108-2118. PubMed ID: 33849741
[TBL] [Abstract][Full Text] [Related]
20. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
Chai Y; Ma Y; Feng W; Lu H; Jin L
World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
